443 results on '"Nakagami H"'
Search Results
2. POS0435 PEPTIDE-BASED VACCINE TARGETING IL17A ATTENUATES EXPERIMENTAL SPONDYLOARTHRITIS INHLA-B27 TRANSGENIC RATS
3. Vaccine targeting ANGPTL3 ameliorates dyslipidemia and associated diseases in mouse models of obese dyslipidemia and familial hypercholesterolemia
4. NFκB Decoy Oligodeoxynucleotide-Based Therapy in Cardiovascular Diseases
5. SWITCH 1/DYAD is a WINGS APART-LIKE antagonist that maintains sister chromatid cohesion in meiosis
6. A MEPS is a MEPS is a MEPS: comparing Ecodesign and Top Runner schemes for setting product efficiency standards
7. Cold shock domain protein A represses angiogenesis and lymphangiogenesis via inhibition of serum response element
8. Current status of the multinational Arabidopsis community
9. NFκB decoy oligodeoxynucleotides ameliorates osteoporosis through inhibition of activation and differentiation of osteoclasts
10. HGF/NK4 inhibited VEGF-induced angiogenesis in in vitro cultured endothelial cells and in vivo rabbit model
11. Inhibition of intimal hyperplasia after balloon injury in rat carotid artery model using cis-element ‘decoy’ of nuclear factor-kB binding site as a novel molecular strategy
12. Gene therapy for preventing neuronal death using hepatocyte growth factor: in vivo gene transfer of HGF to subarachnoid space prevents delayed neuronal death in gerbil hippocampal CA1 neurons
13. Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat and rabbit hindlimb ischemia models: preclinical study for treatment of peripheral arterial disease
14. DEVELOPMENT OF THERAPEUTIC VACCINE FOR GERIATRIC MEDICINE
15. The GYF domain protein PSIG1 dampens the induction of cell death during plant-pathogen interactions
16. The evolution of the US energy service company (ESCO) industry: from ESCO to Super ESCO
17. A novel antithrombotic vaccine against S100A9 without risks of bleeding in ischemic stroke in mice
18. TDM1 Regulation Determines the Number of Meiotic Divisions
19. PEPTIDE-BASED VACCINE TARGETING IL17A ATTENUATES EXPERIMENTAL SPONDYLOARTHRITIS INHLA-B27 TRANSGENIC RATS.
20. The Biphasic Effects of Oxidized-Low Density Lipoprotein on the Vasculogenic Function of Endothelial Progenitor Cells
21. Impact of gastrointestinal residence time of extended-release (ER) tablets on in vivo evaluation of ER tablets
22. A MEPS is a MEPS is a MEPS: comparing Ecodesign and Top Runner schemes for setting product efficiency standards
23. Shotguns in the Front Line: Phosphoproteomics in Plants
24. Gain-switching pulse generation of Tm-doped fiber ring laser pumped with 1.6-µm laser diodes
25. Tunable Operation of Tm-Doped Fiber Ring Laser Controlled by Microbend-Induced Fiber Grating
26. ChemInform Abstract: Novel Violet Pigment, Nostocine A, an Extracellular Metabolite from Cyanobacterium Nostoc spongiaeforme
27. A feasibility study of intravenous (IV) paclitaxel, intraperitoneal (IP) carboplatin, and intraperitoneal paclitaxel (TCipTip therapy) in patients with epithelial ovarian carcinoma.
28. P.275 Application of NFkB decoy ODNs to bone destruction disease
29. Effect of the type of lubricant on the characteristics of orally disintegrating tablets manufactured using the phase transition of sugar alcohol
30. Cold shock domain protein A represses angiogenesis and lymphangiogenesis via inhibition of serum response element
31. Transfection of human hepatocyte growth factor gene ameliorates secondary lymphedema via promotion of lymphangiogenesis
32. O.007 Application of NFκB decoy oligonucleotides to bone metabolic diseases – In vitro and in vivo studies
33. Production of IgA monoclonal antibody against Shiga toxin binding subunits employing nasal-associated lymphoid tissue
34. NADPH oxidase-derived superoxide anion mediates angiotensin II-induced cardiac hypertrophy
35. Attribution of identity in autonomous action.
36. A novel HMG-CoA reductase inhibitor, cerivastatin, suppresses MMP-1 and uPA activities in smooth muscle cells through ETS-1
37. Recurrent arterial thrombotic disease on young onset and protein S deficiency
38. International ESCO business opportunities and challenges: a Japanese case study
39. Priming with angiopoietin-1 augments the vasculogenic potential of the peripheral blood stem cells mobilized with granulocyte colony-stimulating factor through a novel tie2/ets-1 pathway.
40. Transfection of human hepatocyte growth factor gene ameliorates secondary lymphedema via promotion of lymphangiogenesis.
41. Development of a Perfect One-Chip Flexible Servo Controller by Silicon Compilation
42. Statins and myocardial hypertrophy.
43. Roles of angiotensin II type 2 receptor stimulation associated with selective angiotensin II type 1 receptor blockade with valsartan in the improvement of inflammation-induced vascular injury.
44. Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat diabetic hind limb ischemia model: molecular mechanisms of delayed angiogenesis in diabetes.
45. Phosphorylation of p38 mitogen-activated protein kinase downstream of bax-caspase-3 pathway leads to cell death induced by high D-glucose in human endothelial cells.
46. Mitogenic and antiapoptotic actions of hepatocyte growth factor through ERK, STAT3, and AKT in endothelial cells.
47. Anti-apoptotic action of hepatocyte growth factor through mitogen-activated protein kinase on human aortic endothelial cells.
48. Ribozyme oligonucleotides against transforming growth factor-beta inhibited neointimal formation after vascular injury in rat model: potential application of ribozyme strategy to treat cardiovascular disease.
49. Potential contribution of a novel antifibrotic factor, hepatocyte growth factor, to prevention of myocardial fibrosis by angiotensin II blockade in cardiomyopathic hamsters.
50. Cyclic AMP inhibited proliferation of human aortic vascular smooth muscle cells, accompanied by induction of p53 and p21.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.